|
- Dr Makis MD
Dr makis md, a Radiologist, Oncologist, and Cancer Research Specialist with over a decade of experience, specializes in advanced cancer diagnostics and uses high-dose ivermectin to treat cancer, including COVID-vaccine-induced turbo cancer Passionate about leveraging cutting-edge technology, he aims to improve patient outcomes and promote healthcare transparency
- Dr William Makis Cancer Protocols - FirstMed Inc.
Dr William Makis’ Cancer Protocols These are Dr William Makis’ cancer protocols You can find out more about them here and a very recent list of studies that support them here Dr Makis proposes four distinct experimental protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer, the aggressive cancers observed in COVID-19 mRNA vaccinated
- Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr . . .
Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers These protocols, referred to as the “Dr Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer
- Maki vs. Sushi: What Makes the Difference?
Going out for Japanese cuisine can be enjoyable When looking at the menu, though, things might quickly become perplexing Maki vs sushi: can you tell the difference between the two? They have gained so much popularity today If you’re not sure what the differences are, keep reading Fundamental Differences between Maki and Sushi Sushi is a well-known Japanese dish made with vinegared rice
- Dr Makis– The Wellness Company
Dr Makis is also a cancer researcher with over 100 peer-reviewed publications in international medical journals, as well as a best selling author on substack He has studied extensively the "Joe Tippens" protocol surrounding the use of Ivermectin and Mebendazole
- Dr. William Makis – offlabel repurposed drugs for cancer
Dr Makis’ work as a private practice oncologist with off-label repurposed therapies Dr William Makis demonstrably began in September 2024, following the publication of aasten protocol in the Journal of Orthomolecular Medicine, to use ivermectin, fenbendazole and mebendazole as “off-label”, repurposed cancer drugs (isom ca)
- William Makis - Substack
William Makis 1d IVERMECTIN and FENBENDAZOLE Testimonial - 65 year old woman in WALES, UK with Stage 4 Endometrial CarcinoSarcoma reports after 3 months 70
- The Makis Problem: How an Unlicensed Doctor Built a Lucrative . . .
Dr William Makis has pulled off what might be the most brazen medical grift of the digital age Stripped of his medical license and legally branded a vexatious litigant, this former Alberta
|
|
|